Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Ingrid Delaet

Evaluation of Abatacept Administered Subcutaneously in Adults With Active Rheumatoid Arthritis: Impact of Withdrawal and Reintroduction on Immunogenicity, Efficacy and Safety (Phase Iiib ALLOW Study)

Annals of the Rheumatic Diseases

English

Safety of Abatacept Administered Intravenously in Treatment of Rheumatoid Arthritis: Integrated Analyses of Up to 8 Years of Treatment From the Abatacept Clinical Trial Program

Journal of Rheumatology

English

Related publications

The Efficacy and Safety of Abatacept in Rheumatoid Arthritis

Therapeutic Advances in Musculoskeletal Disease

English

Subcutaneously Administered Ofatumumab in Rheumatoid Arthritis: A Phase I/Ii Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics

Journal of Rheumatology

English

Efficacy, Safety, and Tolerability of Abatacept in the Management of Rheumatoid Arthritis

Open Access Rheumatology: Research and Reviews

Rheumatology

2009

English

Effectiveness of Subcutaneously Administered Methotrexate in Patients With Rheumatoid Arthritis

Advances in Clinical and Experimental Medicine

English

Safety and Efficacy of the Selective Costimulation Modulator Abatacept in Patients With Rheumatoid Arthritis Receiving Background Methotrexate: A 5-Year Extended Phase IIB Study

Journal of Rheumatology

English

Efficacy and Safety of Tofacitinib as Monotherapy in Japanese Patients With Active Rheumatoid Arthritis: A 12-Week, Randomized, Phase 2 Study

English

Effects of Abatacept on Monocytes in Patients With Rheumatoid Arthritis

Annals of the Rheumatic Diseases

English

Safety and Immunogenicity of HCV E1E2 Vaccine Adjuvanted With MF59 Administered to Healthy Adults

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Ingrid Delaet

Evaluation of Abatacept Administered Subcutaneously in Adults With Active Rheumatoid Arthritis: Impact of Withdrawal and Reintroduction on Immunogenicity, Efficacy and Safety (Phase Iiib ALLOW Study)

Safety of Abatacept Administered Intravenously in Treatment of Rheumatoid Arthritis: Integrated Analyses of Up to 8 Years of Treatment From the Abatacept Clinical Trial Program

Related publications

The Efficacy and Safety of Abatacept in Rheumatoid Arthritis

Subcutaneously Administered Ofatumumab in Rheumatoid Arthritis: A Phase I/Ii Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics

Efficacy, Safety, and Tolerability of Abatacept in the Management of Rheumatoid Arthritis

Effectiveness of Subcutaneously Administered Methotrexate in Patients With Rheumatoid Arthritis

Safety and Efficacy of the Selective Costimulation Modulator Abatacept in Patients With Rheumatoid Arthritis Receiving Background Methotrexate: A 5-Year Extended Phase IIB Study

Efficacy and Safety of Tofacitinib as Monotherapy in Japanese Patients With Active Rheumatoid Arthritis: A 12-Week, Randomized, Phase 2 Study

Effects of Abatacept on Monocytes in Patients With Rheumatoid Arthritis

Safety and Immunogenicity of HCV E1E2 Vaccine Adjuvanted With MF59 Administered to Healthy Adults